Procurement Summary
Country: Ukraine
Summary: Ambroxol, Solution for Injections/Infusions 7.5 Mg/Ml, 2 Ml Each; Diclofenac Tablets/Capsules of 25 Mg; Diclofenac Tablets/Capsules of 50 Mg; Ethamsylate Solution for Injection, 125 Mg/Ml in 2 Ml; Calcium Chloride Ro...
Deadline: 28 Oct 2026
Posting Date: 25 Oct 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 151452046
Document Ref. No.: UA-2026-10-23-008089-a
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: UAH 35222.2
CPV Classification
33600000 - Pharmaceutical products
33670000 - Medicinal products for the respiratory system
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Ambroxol, solution for injections/infusions 7.5 mg/ml, 2 ml each; Diclofenac tablets/capsules of 25 mg; Diclofenac tablets/capsules of 50 mg; Ethamsylate solution for injection, 125 mg/ml in 2 ml; Calcium chloride solution for injection, 100 mg/ml 5 ml; Lidocaine, spray, 10%, po 38 g; Papaverine, solution for injection, 20 mg/ml, 2 ml each; Tobramycin, eye drops, 3 mg/ml, 5 ml, in a bottle; Famotidine 20 mg tablets; Tolperisone film-coated tablets of 150 mg each; Theophylline solution for injection 20 mg/ml in 5 ml Type of purchase: products Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Etamsylate solution for injection, 125 mg/ml in 2 ml; Famotidine: Classification according to INN: Famotidine, Classification according to ATX: A02BA03, Release form: Tablets, coated with a film cover, Tablets, Dose of the active substance: 20 mg, Type of packaging: Blister NameClassifier and its corresponding codeQuantity/Units of measurementPlace of deliveryDate of deliveryName DK 021:2015: 33600000-6 — Pharmaceutical products Ethamsylate solution for injections, 125 mg/ml by 2 ml; Famotidine: Classification according to INN: Famotidine, Classification according to ATX: A02BA03, Release form: Film-coated tablets, Tablets, Dose of active substance: 20 mg, Packaging type: Blister NameClassifier and its corresponding codeQuantity/Measurement unitsPlace of deliveryDate of deliveryName
Documents
Tender Notice